- Home
- UMAC vs CRVS Comparison
UMAC vs CRVS Comparison
Compare UMAC & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UMAC
- CRVS
- Stock Information
- Founded
- UMAC 2019
- CRVS 2014
- Country
- UMAC United States
- CRVS United States
- Employees
- UMAC N/A
- CRVS N/A
- Industry
- UMAC
- CRVS Biotechnology: Pharmaceutical Preparations
- Sector
- UMAC
- CRVS Health Care
- Exchange
- UMAC Nasdaq
- CRVS Nasdaq
- Market Cap
- UMAC 267.7M
- CRVS 305.4M
- IPO Year
- UMAC 2024
- CRVS 2016
- Fundamental
- Price
- UMAC $9.54
- CRVS $6.16
- Analyst Decision
- UMAC Strong Buy
- CRVS Strong Buy
- Analyst Count
- UMAC 3
- CRVS 4
- Target Price
- UMAC $17.67
- CRVS $15.00
- AVG Volume (30 Days)
- UMAC 2.5M
- CRVS 580.5K
- Earning Date
- UMAC 08-14-2025
- CRVS 08-07-2025
- Dividend Yield
- UMAC N/A
- CRVS N/A
- EPS Growth
- UMAC N/A
- CRVS N/A
- EPS
- UMAC N/A
- CRVS N/A
- Revenue
- UMAC $7,701,550.00
- CRVS N/A
- Revenue This Year
- UMAC $100.69
- CRVS N/A
- Revenue Next Year
- UMAC $92.24
- CRVS N/A
- P/E Ratio
- UMAC N/A
- CRVS N/A
- Revenue Growth
- UMAC 279.38
- CRVS N/A
- 52 Week Low
- UMAC $1.28
- CRVS $2.54
- 52 Week High
- UMAC $23.62
- CRVS $10.00
- Technical
- Relative Strength Index (RSI)
- UMAC 46.92
- CRVS 73.40
- Support Level
- UMAC $8.65
- CRVS $5.58
- Resistance Level
- UMAC $9.39
- CRVS $5.99
- Average True Range (ATR)
- UMAC 0.87
- CRVS 0.33
- MACD
- UMAC -0.16
- CRVS 0.04
- Stochastic Oscillator
- UMAC 26.93
- CRVS 99.12
About UMAC Unusual Machines Inc. Common Stock
Unusual Machines Inc is engaged in serving the American drone industry by building and selling drone components.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).